---
input_text: 'Phenotype of GABA-transaminase deficiency.OBJECTIVE: We report a case
  series of 10 patients with gamma-aminobutyric acid (GABA)-transaminase deficiency
  including a novel therapeutic trial and an expanded phenotype. METHODS: Case ascertainment,
  literature review, comprehensive evaluations, and long-term treatment with flumazenil.
  RESULTS: All patients presented with neonatal or early infantile-onset encephalopathy;
  other features were hypotonia, hypersomnolence, epilepsy, choreoathetosis, and accelerated
  linear growth. EEGs showed burst-suppression, modified hypsarrhythmia, multifocal
  spikes, and generalized spike-wave. Five of the 10 patients are currently alive
  with age at last follow-up between 18 months and 9.5 years. Treatment with continuous
  flumazenil was implemented in 2 patients. One patient, with a milder phenotype,
  began treatment at age 21 months and has continued for 20 months with improved alertness
  and less excessive adventitious movements. The second patient had a more severe
  phenotype and was 7 years of age at initiation of flumazenil, which was not continued.
  CONCLUSIONS: GABA-transaminase deficiency presents with neonatal or infantile-onset
  encephalopathy including hypersomnolence and choreoathetosis. A widened phenotypic
  spectrum is reported as opposed to lethality by 2 years of age. The GABA-A benzodiazepine
  receptor antagonist flumazenil may represent a therapeutic strategy.'
raw_completion_output: |-
  action: <long-term treatment with flumazenil; Treatment with continuous flumazenil>
  disease: <GABA-transaminase deficiency; neonatal or infantile-onset encephalopathy; epilepsy>
  symptom: <hypotonia; hypersomnolence; choreoathetosis; accelerated linear growth; excessive adventitious movements>
  action_to_disease: <long-term treatment with flumazenil TREATS GABA-transaminase deficiency; Treatment with continuous flumazenil TREATS neonatal or infantile-onset encephalopathy; Treatment with continuous flumazenil TREATS epilepsy>
  action_to_symptom: <Treatment with continuous flumazenil IS USED TO TREAT excessive adventitious movements>
  triples: <long-term treatment with flumazenil TREATS GABA-transaminase deficiency; Treatment with continuous flumazenil TREATS neonatal or infantile-onset encephalopathy; Treatment with continuous flumazenil TREATS epilepsy; Treatment with continuous flumazenil IS USED TO TREAT excessive adventitious movements>
prompt: |+
  From the text below, extract the following entities in the following format:

  subject: <the value for subject>
  predicate: <the value for predicate>
  object: <the value for object>
  qualifier: <A qualifier for the statements, e.g. "NOT" for negation>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Treatment with continuous flumazenil IS USED TO TREAT excessive adventitious movements>

  ===

extracted_object:
  triples:
    - subject: long-term treatment with flumazenil
      predicate: TREATS
      object: GABA-transaminase deficiency
    - subject: Treatment with continuous flumazenil
      predicate: TREATS
      object: encephalopathy
      object_qualifier: neonatal or infantile-onset
    - subject: Treatment with continuous flumazenil
      predicate: TREATS
      object: epilepsy
    - subject: Treatment with continuous flumazenil
      predicate: IS USED TO TREAT
      object: excessive adventitious movements
  action:
    - <long-term treatment with flumazenil
    - Treatment with continuous flumazenil>
  disease:
    - <GABA-transaminase deficiency
    - neonatal or infantile-onset encephalopathy
    - epilepsy>
  symptom:
    - <hypotonia
    - hypersomnolence
    - HP:0001266
    - HP:0000098
    - excessive adventitious movements>
  action_to_disease:
    - subject: long-term treatment with flumazenil
      predicate: TREATS
      object:
        - MONDO:0013166
      subject_qualifier: long-term
    - subject: continuous flumazenil
      predicate: TREATS
      object:
        - neonatal encephalopathy
        - infantile-onset encephalopathy
    - subject: continuous flumazenil
      predicate: TREATS
      object:
        - MONDO:0005027
  action_to_symptom:
    - subject: continuous flumazenil
      predicate: IS USED TO TREAT
      object:
        - excessive adventitious movements
named_entities:
  - id: MONDO:0005365
    label: hearing loss
  - id: MONDO:0008891
    label: Brown-Vialetto-Van Laere syndrome
  - id: MONDO:0003608
    label: optic atrophy
  - id: MONDO:0100062
    label: infantile spasms
  - id: MONDO:0005027
    label: seizures
  - id: MONDO:0005047
    label: infertility
  - id: MAXO:0010030
    label: bone marrow transplantation
  - id: MONDO:0009974
    label: familial hemophagocytic lymphohistiocytosis
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: MONDO:0000440
    label: Metabolic acidosis
  - id: MONDO:0009666
    label: Holocarboxylase synthetase deficiency
  - id: MONDO:0015454
    label: Multiple carboxylase deficiency
  - id: MONDO:0001531
    label: Coagulopathy
  - id: MONDO:0020300
    label: Autosomal dominant nocturnal frontal lobe epilepsy
  - id: MONDO:0000903
    label: myoclonus-dystonia
  - id: MAXO:0000943
    label: Deep brain stimulation
  - id: HP:0001252
    label: Hypotonia
  - id: MAXO:0001082
    label: Trabeculectomy
  - id: MONDO:0005129
    label: Cataract
  - id: HP:0000253
    label: Progressive microcephaly
  - id: HP:0001263
    label: Global developmental delay
  - id: MONDO:0004183
    label: axonal neuropathy
  - id: HP:0011096
    label: demyelination
  - id: MONDO:0008961
    label: autosomal recessive demyelinating Charcot-Marie-Tooth disease type 4A
  - id: MONDO:0007947
    label: Marfan's syndrome
  - id: MONDO:0004691
    label: <Autosomal dominant polycystic kidney disease (ADPKD)
  - id: MONDO:0005015
    label: Diabetes mellitus
  - id: MONDO:0004522
    label: Peritonitis
  - id: MAXO:0000603
    label: Peritoneal Dialysis
  - id: MONDO:0003441
    label: dystonia
  - id: MONDO:0001341
    label: IgA deficiency
  - id: MONDO:0009693
    label: multiple myeloma
  - id: MONDO:0011787
    label: Limb-girdle muscular dystrophy type 2I (LGMD2I)
  - id: MONDO:0009662
    label: <MPS VII (Sly disease)
  - id: MONDO:0020546
    label: acute GVHD
  - id: MONDO:0005155
    label: Liver cirrhosis
  - id: MONDO:0002771
    label: Pulmonary fibrosis
  - id: MONDO:0004992
    label: Cancer
  - id: HP:0003394
    label: Muscle cramps
  - id: MONDO:0015286
    label: <Complete DiGeorge syndrome (cDGS)
  - id: MONDO:0019098
    label: Autoimmune thrombocytopenia
  - id: MONDO:0004126
    label: Thyroiditis
  - id: MONDO:0002049
    label: Thrombocytopenia
  - id: MAXO:0010042
    label: Thymus transplantation
  - id: MONDO:0010421
    label: X-linked Agammaglobulinemia
  - id: MONDO:0007765
    label: Hyperostosis cranialis interna
  - id: MAXO:0000780
    label: growth hormone therapy
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: HP:0004322
    label: short stature
  - id: MONDO:0015168
    label: Arthrogryposis multiplex congenita
  - id: MONDO:0018940
    label: Congenital myasthenic syndromes
  - id: MAXO:0001077
    label: splenectomy
  - id: MONDO:0010518
    label: Wiskott-Aldrich syndrome
  - id: MONDO:0011724
    label: Glut-1 deficiency syndrome
  - id: HP:0005484
    label: acquired microcephaly
  - id: HP:0001257
    label: spasticity
  - id: HP:0001251
    label: ataxia
  - id: HP:0011972
    label: hypoglycorrhachia
  - id: MAXO:0000098
    label: Fasting
  - id: MONDO:0019169
    label: Pyruvate dehydrogenase complex deficiency
  - id: MONDO:0000188
    label: GLUT1 deficiency syndrome
  - id: HP:0001250
    label: Seizures
  - id: HP:0001946
    label: Ketosis
  - id: MONDO:0019353
    label: Stargardt disease
  - id: MONDO:0015974
    label: Severe Combined Immune Deficiency (SCID)
  - id: MONDO:0004980
    label: eczema
  - id: MONDO:0007179
    label: autoimmunity
  - id: HP:0001892
    label: hemorrhagic diathesis
  - id: HP:0000964
    label: eczema
  - id: HP:0002960
    label: autoimmunity
  - id: MONDO:0009561
    label: alpha-mannosidosis
  - id: MAXO:0000011
    label: physical therapy
  - id: MAXO:0010203
    label: echocardiography
  - id: MONDO:0005380
    label: avascular necrosis
  - id: MONDO:0005149
    label: pulmonary hypertension
  - id: MONDO:0005632
    label: acute chest syndrome
  - id: MAXO:0000652
    label: angiotensin-converting enzyme inhibitor therapy
  - id: MONDO:0800385
    label: iron overload
  - id: MAXO:0035078
    label: pulmonary function testing
  - id: MONDO:0009061
    label: cystic fibrosis
  - id: MONDO:0010926
    label: familial hypocalciuric hypercalcemia type 3 (FHH3)
  - id: MONDO:0001566
    label: hypercalcemia
  - id: HP:0001508
    label: poor weight gain
  - id: MAXO:0035059
    label: Nerve conduction studies
  - id: MAXO:0010033
    label: Umbilical cord blood transplantation
  - id: MONDO:0018868
    label: metachromatic leukodystrophy
  - id: MONDO:0009216
    label: Fanconi-Bickel syndrome
  - id: MONDO:0019499
    label: Turner syndrome
  - id: MONDO:0005041
    label: glaucoma
  - id: HP:0001260
    label: Dysarthric speech
  - id: HP:0000958
    label: Dry skin
  - id: MONDO:0019234
    label: Peroxisome biogenesis disorder
  - id: MONDO:0020236
    label: ectopia lentis
  - id: HP:0001336
    label: Myoclonus
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0010626
    label: X-linked hyper-IgM syndrome
  - id: MAXO:0000427
    label: brain MRI
  - id: MAXO:0000431
    label: breast MRI
  - id: MAXO:0010363
    label: mammography
  - id: MAXO:0000527
    label: physical examination
  - id: MAXO:0001184
    label: colonoscopy
  - id: MONDO:0018875
    label: Li-Fraumeni syndrome
  - id: MONDO:0021055
    label: Familial amyloid polyneuropathy (FAP)>
  - id: MAXO:0001175
    label: Liver transplantation
  - id: MONDO:0005154
    label: Liver disease
  - id: MONDO:0018881
    label: myelodysplastic syndrome
  - id: MONDO:0018874
    label: acute myelogenous leukemia
  - id: MONDO:0013730
    label: GVHD
  - id: MONDO:0042982
    label: GATA2 deficiency
  - id: MONDO:0004737
    label: Homocystinuria
  - id: MONDO:0010998
    label: ALG3-CDG
  - id: HP:0001510
    label: growth retardation
  - id: HP:0000252
    label: microcephaly
  - id: MONDO:0024327
    label: chronic renal failure
  - id: HP:0004325
    label: low body weight
  - id: HP:0003712
    label: Muscular hypertrophy
  - id: MAXO:0009004
    label: Exome sequencing
  - id: MONDO:0004994
    label: cardiomyopathies
  - id: HP:0000339
    label: pugilistic facies
  - id: MAXO:0000088
    label: Dietary interventions
  - id: MONDO:0009861
    label: Phenylketonuria
  - id: HP:0001266
    label: choreoathetosis
  - id: HP:0000098
    label: accelerated linear growth
  - id: MONDO:0013166
    label: GABA-transaminase deficiency
